[1]李悦斐,许 坚,陈武君,等.小柴胡汤联合痰热清治疗肺心病疗效及对患者炎症因子的影响[J].陕西中医,2022,(12):1709-1712.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.013]
 LI Yuefei,XU Jian,CHEN Wujun,et al.Effect of Xiaochaihu decoction combined with Tanreqing on pulmonary heart disease and its influence on inflammatory factors[J].,2022,(12):1709-1712.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.013]
点击复制

小柴胡汤联合痰热清治疗肺心病疗效及对患者炎症因子的影响
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年12期
页码:
1709-1712
栏目:
临床研究
出版日期:
2022-12-20

文章信息/Info

Title:
Effect of Xiaochaihu decoction combined with Tanreqing on pulmonary heart disease and its influence on inflammatory factors
作者:
李悦斐1许 坚1陈武君2陈湛生3
(1.广州中医药大学,广东 广州 510006; 2.前海人寿广州总医院,广东 广州 510000; 3.广东燕岭医院,广东 广州 510507)
Author(s):
LI YuefeiXU JianCHEN WujunCHEN Zhansheng
(Guangzhou University of Chinese Medicine,Guangzhou 510006,China)
关键词:
慢性肺源性心脏病 小柴胡汤 痰热清注射液 肺功能 炎症反应 生存率
Keywords:
Chronic pulmonary heart disease Xiaochaihu decoction Tanreqing injection Lung function Inflammatory response Survival rate
分类号:
R 541.5
DOI:
DOI:10.3969/j.issn.1000-7369.2022.12.013
文献标志码:
A
摘要:
目的:探讨小柴胡汤联合痰热清注射液治疗慢性肺源性心脏病(CCP)预后及对患者炎症因子水平的影响。方法:选取100例CCP患者为研究对象,抽签分为观察组(n=50)、对照组(n=50)。对照组给予痰热清注射液,观察组在对照组基础上加用小柴胡汤,比较两组临床疗效及预后情况。结果:观察组患者治疗总有效率高于对照组,治疗后观察组各项积分均低于对照组。观察组治疗后血氧分压、肺泡气氧分压均高于对照组,二氧化碳分压、肺动脉压力均低于对照组。治疗后观察组内皮素-1、白介素-8、肿瘤坏死因子-α、血管紧张素Ⅱ水平均低于对照组,差异有统计学意义(均P<0.05)。观察组再入院率、病死率低于对照组,差异有统计学意义(均P<0.05)。结论:小柴胡汤联合痰热清注射液治疗CCP效果较好,且能有效抑制炎症反应。
Abstract:
Objective:To study effect of Xiaochaihu decoction combined with Tanreqing injection on the prognosis and inflammatory factor levels of chronic pulmonary heart disease(CCP).Methods:100 CCP patients diagnosed CCP were selected and divided into observation group(n=50)and control group(n=50)by drawing lots.The control group were given Tanreqing injection,and the observation group treated with Xiaochaihu decoction on the basis of the control group.The clinical efficacy and prognosis of the two groups were compared.Results:The total effective rate of the observation group was significantly higher than that in the control group.After treatment,the scores of the observation group were lower than that in the control group.The blood oxygen partial pressure and alveolar oxygen partial pressure in the observation group were higher than those in the control group.The levels of carbon dioxide partial pressure and pulmonary artery pressure were lower than those in the control group.After treatment,the levels of Endothelin-1,Interleukin-8,TNF-α and Angiotensin Ⅱ in the observation group were lower than those in the control group,difference statistically significant(all P<0.05).The readmission rate and mortality rate in the observation group were lower than those in the control group,difference statistically significant(all P<0.05).Conclusion:Xiaochaihu decoction combined with Tanreqing injection has better effect on CCP,and can effectively inhibit the inflammatory reaction.

参考文献/References:

[1] 李 倩,沈 林,方 妍,等.心电向量图在慢性肺源性心脏病早期诊断中的作用[J].重庆医学,2018,47(11):1534-1535.
[2] 胡良英,苏美霞,蒋景华,等.慢性肺源性心脏病老年患者呼吸道感染病原菌和耐药分析[J].中华医院感染学杂志,2018,28(11):1650-1653.
[3] 庞海江.通脉逐瘀方联合阿司匹林治疗肺心病急性加重期合并全身炎症反应综合征疗效及对患者血浆D-二聚体、IL-6、BNP的影响[J].陕西中医,2018,39(7):873-875.
[4] 徐 婕,曾龙飞,龚建祖,等.低分子肝素钙皮下注射治疗慢性阻塞性肺疾病急性加重期合并肺心病的疗效[J].实用医学杂志,2018,34(9):1537-1540.
[5] 张晓华,胡玉凤,罗光明,等.Tei指数对尘肺病合并肺心病患者右心功能的评价作用[J].重庆医学,2020,49(6):914-917.
[6] 刘 魏,靳玉梅,窦 红,等.川芎嗪联合环磷腺苷葡胺治疗肺尘埃沉着病合并肺心病患者的临床效果[J].中国老年学杂志,2018,38(7):1614-1616.
[7] 中华医学会.慢性肺源性心脏病基层诊疗指南[J].中华全科医师杂志,2018,17(12):959-965.
[8] 中华中医药学会肺系病专业委员会.慢性肺源性心脏病中医诊疗指南[J].中医杂志,2014,55(6):526-531.
[9] 吕佳康.慢性阻塞性肺疾病中药新药临床研究指导原则制定的可行性探讨[J].中国临床药理学杂志,2013,29(6):477-480.
[10] 陈晓飞,应华娟,李 盛,等.MSCT诊断慢性阻塞性肺疾病合并慢性肺源性心脏病[J].中国医学影像技术,2018,34(10):1504-1508.
[11] 叶红梅,代 娟,宁 珍.二维斑点追踪联合组织多普勒对肺心病左心功能及同步性评价的研究[J].中国超声医学杂志,2019,35(5):409-412.
[12] 钏丽波,王 丹,陈国兵,等.BiPAP呼吸机联合坎地沙坦酯对肺心病急性期合并呼吸衰竭老年患者心肺功能及血清内皮素-1、Clara细胞蛋白和Copeptin水平的影响[J].中国老年学杂志,2020,40(1):1-4.
[13] 蔡亚宏,蔡文锋,熊 丹.小柴胡汤改善慢性肾小球肾炎患者炎症及减轻蛋白尿的作用研究[J].陕西中医,2018,39(10):1405-1407.
[14] 白宇望,杨利生,魏光明.小柴胡汤加减方治疗上呼吸道感染发热临床研究[J].陕西中医,2019,40(2):223-225.
[15] 黄菲菲,李耀浙,张 婷,等.红景天苷通过抑制氧化应激防治大鼠低氧性肺动脉高压[J].中国病理生理杂志,2018,34(3):500-506.
[16] 王 蕊,尚粉青,叶玉兰,等.KLF2在肺动脉高压大鼠肺组织中的表达及机制探讨[J].陕西医学杂志,2020,49(8):919-922.
[17] 王全宏,蔡宇星,徐 辉.心脏超声在重症监护室肺动脉高压患者肺血管压力和右心功能评估中的应用分析[J].陕西医学杂志,2019,48(7):863-866.
[18] 马民凯,马红建,陈新苗.通络散结汤对3期糖尿病肾病患者GFR、UAER、β2-MG、Cys-C及微炎症状态的影响[J].陕西中医,2020,41(10):1432-1435.
[19] 赵珍珍,史艳平,邱 锐,等.清热活血方联合阿奇霉素治疗儿童肺炎支原体肺炎临床研究[J].陕西中医,2021,42(5):616-619.
[20] 段丽颖,王绍宁,那 铎,等.双黄芩素氧钒配合物的抗氧化性和抑菌活性[J].沈阳药科大学学报,2018,35(7):581-586.
[21] 赵含笑,于天启.黄芩苷对多发性骨髓瘤细胞株U266增殖、凋亡、侵袭的影响[J].山东医药,2018,58(47):28-31.

相似文献/References:

[1]雷 霏,高彩霞.小柴胡汤加减对代谢相关性脂肪性肝病患者肝功能及胰岛素抵抗的影响[J].陕西中医,2022,(7):890.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.018]
 LEI Fei,GAO Caixia.Effect of modified Xiaochaihu decoction on liver function and insulin resistance in patients with metabolic-related fatty liver disease[J].,2022,(12):890.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.018]
[2]张 真,刘 俊,王 慧,等.基于聚散理论从形与气探讨慢性肺源性心脏病治疗机制[J].陕西中医,2023,(3):337.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.015]
[3]田 菲,张晓杰,苗春澍,等.小柴胡汤合五苓散治疗慢性湿疹疗效及对患者中医证候积分和焦虑、抑郁状态的影响[J].陕西中医,2023,(6):738.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.012]
 TIAN Fei,ZHANG Xiaojie,MIAO Chunshu,et al.Efficacy of Xiaochaihu decoction with Wuling powder in the treatment of patients with chronic eczema and its effects on TCM syndromes scores and anxiety and depression[J].,2023,(12):738.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.012]
[4]袁 冰,袁 洁,黄凯琳,等.基于“心脾相关,调气为先”探讨双心病中医治疗[J].陕西中医,2024,(11):1529.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.019]
 YUAN Bing,YUAN Jie,HUANG Kailin,et al.Based on “heart-spleen correlation,regulating Qi first” to explore Chinese medicine treatment of double heart disease[J].,2024,(12):1529.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.019]
[5]刘果果,龙卫平,石 磊,等.小柴胡汤合炙甘草汤治疗新型冠状病毒感染相关性心肌炎临床研究[J].陕西中医,2024,(12):1634.[doi:DOI:10.3969/j.issn.1000-7369.2024.12.010]
 LIU Guoguo,LONG Weiping,SHI Lei,et al.Observation on the effect of Xiaochaihu decoction combined with Zhigancao decoction in intervening myocarditis associated with novel coronavirus infection[J].,2024,(12):1634.[doi:DOI:10.3969/j.issn.1000-7369.2024.12.010]

备注/Memo

备注/Memo:
基金项目:广东省中医药局科研项目(20171285)
更新日期/Last Update: 2022-12-09